CrisprBits collaborates with Molbio Diagnostics to launch CRISPR-based Point-of-Care tests
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
The blood test market worldwide is today around $75-80 billion
This drive will expand access to quality diagnostics and help find the ‘missing millions’ – patients that are suffering from TB but not registered in the healthcare system
It is a point-of-care portable, battery-operated, IoT-enabled platform with a sample to result in less than 1 hour
Medtech plays a vital role in the healthcare system and players in this field believe that the budget should address some of their concerns if India has to become a formidable player
Molbio Diagnostics has been the pioneer in providing access to molecular testing through its Truenat Real Time PCR platform. Sriram Natarajan, Director & CEO, of the company shares his experiences on the journey so far in an interview with Thomas C Thottathil
An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion
Nipah virus (NiV) is an emerging zoonotic disease that causes severe disease in humans. Signs and symptoms range from asymptomatic to acute respiratory infection and fatal encephalitis
Subscribe To Our Newsletter & Stay Updated